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Abstract We describe a novel approach to assess toxicity to the
free-living nematode Caenorhabditis elegans that relies on the
ability of firefly luciferase to report on endogenous ATP levels.
We have constructed bioluminescent C. elegans with the luc gene
under control of a constitutive promoter. Light reduction was
observed in response to increasing temperature, concentrations of
copper, lead and 3,5-dichlorophenol. This was due to increased
mortality coupled with decreased metabolic activity in the
surviving animals. The light emitted by the transgenic nematodes
gave a rapid, real-time indication of metabolic status. This forms
the basis of rapid and biologically relevant toxicity tests. ß 2001
Published by Elsevier Science B.V. on behalf of the Federation
of European Biochemical Societies.
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1. Introduction
Whole cell biosensors o¡er a powerful new approach to
environmental monitoring and toxicity testing, measuring bio-
availability of toxins and biological e¡ects rather than total
concentrations obtained by traditional analytical techniques
[1]. The free-living soil nematode Caenorhabditis elegans is
an excellent candidate for a biosensor that represents multi-
cellular eukaryotes [2]. Sensitivity of C. elegans to many heavy
metals is similar to that of mammals [3] indicating potential
for evaluating toxicity to humans.
Here we demonstrate the assessment of bioavailability and
toxicity of xenobiotics by changes in the metabolic state of C.
elegans, as measured in vivo by ¢re£y luciferase luminescence.
The ¢re£y luciferase catalyses the oxidation of luciferin, a
reaction that requires ATP and produces light [4]. When the
other substrates are in excess, the amount of light emitted
re£ects the ATP levels and provides a measure of the meta-
bolic state of the organism [5,6]. The use of ¢re£y luciferase to
speci¢cally measure ATP is standard practice and has been
validated in vivo by comparison with conventional ATP as-
says [6]. Any conditions a¡ecting metabolism of the lumines-
cent biosensor can be detected by a change in light levels [1,7].
In this study, we have constructed bioluminescent C. elegans
and describe their use as biosensors by exposure to elevated
temperature, the heavy metals copper and lead and the orga-
noxenobiotic 3,5-dichlorophenol (3,5-DCP), commonly used
as a wood preservative. This forms the basis of a robust, rapid
and biologically relevant approach to toxicity testing and ad-
dresses ethical concerns by providing an alternative to testing
on higher eukaryotes.
2. Materials and methods
2.1. Nematode culture
C. elegans was routinely cultured at 25‡C on NGM agar plates with
Escherichia coli OP50 as a food source [8]. Liquid culture was carried
out in complete S medium [9] supplemented with 40 g (wet weight) l31
of E. coli OP50, at 25‡C and 160 rpm. Medium (100 ml) was inocu-
lated with the worms washed from two 6 cm NGM plates and incu-
bated for 5 days.
2.2. Construction of luc marked C. elegans
A luc gene with a deleted peroxisome targeting sequence (lucv) [7]
was placed under control of the C. elegans constitutive promoter let-
858 [10] present in the vector pPD103.05 [11], to create the plasmid
pPECL1. This leads to constitutive expression of cytosolic ¢re£y lu-
ciferase in all cells of the nematode [10]. pPECL1 was diluted together
with pRF4 (harbouring the dominant collagen mutation, rol-6-
(su1006), which confers a roller phenotype [12]) in TE, to a concen-
tration of 200 Wg ml31 each and microinjected into the gonads of
wild-type C. elegans strain N2 [13]. F1 roller progeny were selected
to establish stable transgenic lines. A spontaneously integrated line
(100% transmission rate), designated strain PE39 (feIs1[rol-6(su1006)
let-858 : :lucv]), was selected for the present work.
2.3. Measurement of luminescence in vivo
Nematodes were centrifuged (2 min, 200Ug), washed once in citric
phosphate bu¡er at pH 6.5 supplemented with 1% dimethyl sulphox-
ide (DMSO) and 0.05% Triton X-100 (to increase permeability of
luciferin), resuspended in 5 ml of the same bu¡er and split into four
replicate 1 ml samples in luminometer cuvettes (Clinicon). Lumines-
cence was measured after 30 min incubation with D-luciferin (100 WM,
Molecular Probes) to obtain maximum levels, except where stated
otherwise. A BioOrbit 1251 luminometer and the Multiuse software
package (version 1.01) were used; measurements were integrated over
a period of 12 s, at 25‡C with shaking; and results expressed in rel-
ative light units (RLU), where 1 RLU equals 10 mV ml31 s31. Back-
ground readings were subtracted from sample readings. Wild-type C.
elegans (strain N2) provided with luciferin yielded background lumi-
nescence readings. Light levels were expressed as % of the maximum
luminescence per nematode (total numbers) or per live nematode,
obtained for controls (exposure to 25‡C and ddH2O).
2.4. Measurement of luminescence in vitro
Worms used in bioassays were resuspended in 50 Wl ddH2O, frozen
in liquid nitrogen and kept at 370‡C until further analysis. The com-
mercial kit ‘Luciferase Assay System’ (Promega) was then used ac-
cording to the manufacturer’s instructions. Brie£y, the frozen samples
were ground to ¢ne powder using a small handheld pestle (Konte)
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precooled in liquid nitrogen. Lysis reagent was added to the samples
and broken down further (15 strokes). Samples were incubated on ice
for 15 min and the mixing process was repeated. Tissue debris was
removed by centrifugation (4‡C, 12 000Ug). The cleared extract and
the luciferase assay reagent were equilibrated to 25‡C prior to mixing
and measurement of luminescence. Settings for the luminometer were
as for the in vivo measurements. Addition of a cocktail of protease
inhibitors (aprotinin, leupeptin, pepstatin, phenylmethylsulphonyl £u-
oride and chymostatin) prior to grinding samples did not increase
¢nal luminescence readings.
2.5. Bioassay conditions
The nematodes were grown in liquid culture and collected by cen-
trifugation (2 min, 200Ug, room temperature) in 50 ml tubes (Nunc).
Nematode density in bioassays was approximately 1U104 ml31. Prior
to exposure to the various bioassay conditions nematodes were
washed in ddH2O, followed by a wash in the test solution/ddH2O
at the test temperature and resuspension in 10 ml of fresh test solu-
tion/ddH2O at the test temperature. In the temperature assay, incu-
bation was carried out for 1 h at 24, 31 or 36‡C in orbital incubators
(160 rpm). Exposure to copper, lead or 3,5-DCP solutions was carried
out for 2 h, at 25‡C and 160 rpm. The concentrations tested were 0,
0.08, 0.16, 0.24, 0.40, 0.8 and 1.6 mM copper (CuSO4W5H2O), 0, 0.025,
0.05, 0.075, 0.125, 0.25 and 0.5 mM lead (Pb(NO3)2) and 0, 0.09, 0.18,
0.27, 0.36, 0.45 and 0.6 mM 3,5-DCP in ddH2O and were all adjusted
to pH 5.5. Test solutions were prepared fresh from acidi¢ed (1% 1 N
nitric oxide) 16 mM copper and 5 mM lead stocks or from a 3 mM
stock of 3,5-DCP. All glassware was acid washed. Measurement of
luminescence was performed at 25‡C after resuspension in fresh bu¡er
as described above. Bioassays were performed on separate occasions
and the trends found to be identical.
2.6. Enumeration of nematodes and assessment of lethality
The total number of worms in 5 Wl aliquots from each luminometer
cuvette was determined using a counting cell. Nematode numbers in
replicate cuvettes did not di¡er signi¢cantly in any of the experiments.
To estimate lethality, 5 Wl samples of each suspension were placed on
NGM plates. Immobile worms that failed to respond to probing with
a needle were scored as dead. Addition of 1% DMSO and 0.05%
Triton X-100 prior to luminescence readings had no e¡ect on lethality.
2.7. Statistical analysis
A signi¢cance level of 0.05 was chosen. Analysis of variance was
carried out on nematode numbers, temperature bioassay and in vitro
assays. Least signi¢cant di¡erences (5%) were calculated when
P9 0.05. Regression analysis was carried out for the copper, lead
or 3,5-DCP bioassays.
3. Results
3.1. E¡ect of thermal stress, copper, lead and 3,5-DCP on
C. elegans bioluminescence (bioassays)
Lethality was very low in the thermal stress experiment
(0.5% at 24‡C, 1.2% at 31‡C and 1.6% at 36‡C). Nematodes
were resuspended in bu¡er at 25‡C prior to luminescence mea-
surements, so that dependence of luciferase activity on tem-
perature did not interfere with assessment of metabolic status.
Exposure to 31 and 36‡C led to a signi¢cant decrease in light
output per live nematode, as measured 5 min after adding
luciferin (Fig. 1). Light levels of nematodes exposed to 31
and 36‡C recovered partially when they were incubated at
Fig. 1. E¡ect of elevated temperatures on C. elegans biolumines-
cence. Thermal stress temperatures were 31 and 36‡C, whereas 24‡C
is within the C. elegans normal growth range. Luminescence was
measured after resuspension of the nematodes in bu¡er at 25‡C,
5 min (E) and 30 min (F) after adding luciferin. Data are expressed
as a percentage of the maximum luminescence per live nematode.
Error bars represent the S.E.M. of four replicates.
Fig. 2. E¡ect of copper, lead and 3,5-DCP on bioluminescence and
lethality of C. elegans. Error bars represent the S.E.M. of four repli-
cates. A: Luminescence per nematode (F) or per live nematode (E)
after exposure to copper. B: Luminescence per nematode (R) or
per live nematode (O) after exposure to lead. C: Luminescence per
nematode (b) or per live nematode (a) after exposure to 3,5-DCP.
+, lethality.
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25‡C for 30 min prior to measuring. After this period of time,
the light output of nematodes exposed to 31‡C was no longer
signi¢cantly lower than that of 24‡C samples, but that of 36‡C
samples was still signi¢cantly lower than the others.
Exposure of the nematodes to copper or lead resulted in
considerable lethality and decreased light levels (Fig. 2A,B).
The regressions of log10(% of maximum luminescence per to-
tal or per live nematode) on copper concentration were both
highly signi¢cant and explained most of the variability in bio-
luminescence (r2 = 94.4 and 91.2% respectively, P6 0.001 for
both). Thus, light output per total number of nematodes and
per live nematode signi¢cantly decreased with increasing cop-
per concentrations. These data indicate that lethality alone did
not account for luminescence decline and surviving nematodes
emitted less light. The decline in luminescence with increasing
concentration of lead was signi¢cant (r2 = 77.6%, P6 0.001).
In contrast, when data were analysed per live nematode, the
regression explained very little of the variability in biolumi-
nescence (r2 = 49.8%). This suggested that lethality was re-
sponsible for most of the decrease in luminescence in this
experiment.
Luminescence and lethality in the 3,5-DCP bioassay are
shown in Fig. 2C. The regressions of log10(% of maximum
luminescence per total or per live nematode) on 3,5-DCP con-
centration were both highly signi¢cant (r2 = 93.6 and 94.8%
respectively, P6 0.001 for both). Lethality was very low (less
than 5%) up to 0.36 mM 3,5-DCP, whereas luminescence
decreased dramatically with increasing exposure levels, declin-
ing to 20% of its maximum upon exposure to 0.36 mM 3,5-
DCP. Hence, the e¡ect of mortality was negligible in this
experiment and luminescence decline resulted from sublethal
e¡ects.
3.2. E¡ect of thermal stress, copper and 3,5-DCP on luciferase
expression and activity (in vitro assays)
Di¡erential expression of the lucv transgene or alterations
in the activity of luciferase, rather than changes in metabolic
activity, might account for the observed decrease in biolumi-
nescence upon exposure of the transgenic worms to elevated
temperatures (Fig. 1), copper or 3,5-DCP (Fig. 2). In order to
investigate this possibility, in vitro luciferase assays were car-
ried out on the nematodes exposed to temperature, copper
and 3,5-DCP. In these assays, ATP was provided at a satu-
rating concentration (veri¢ed experimentally by increasing the
ATP concentration by a factor of two with no change in light
levels), so that di¡erences in light output re£ected levels of
active luciferase in cells. Bioluminescence values were divided
by the number of live nematodes in the sample at the point of
freezing and expressed as the percentage of maximum lumi-
nescence per ‘live’ nematode.
There was no evidence (Ps 0.05) for altered luciferase lev-
els or activity in samples exposed to 24, 31 and 36‡C (Fig. 3)
or to the various concentrations of 3,5-DCP (Fig. 4). In vitro
luminescence of samples exposed to 0.16^1.6 mM copper was
depressed when compared to that of low levels of copper (0
and 0.08 mM) (Fig. 4). Nevertheless, increasing copper levels
from 0.16 to 1.6 mM did not decrease in vitro luminescence
further. Exposure to copper at concentrations higher than
0.08 mM led to a decrease in expression of the lucv and/or
activity of luciferase. However, further increases in copper
levels did not decrease expression of the lucv and/or activity
of luciferase further. This contrasted with the continuous de-
cline in the in vivo assay (Fig. 2), observed for nematodes
exposed to low levels of copper or increasing concentrations
of the metal.
4. Discussion
Here we report the ¢rst example of transgenic C. elegans
expressing luciferase and the use of in vivo luminescence as a
measurement of the toxic e¡ect of compounds on this multi-
cellular eukaryote. Bioluminescent nematodes responded to
representative environmental stresses (increasing temperatures
and concentrations of copper, lead and 3,5-DCP) by a de-
Fig. 3. In vitro luminescence of extracts of nematodes exposed to
di¡erent temperatures. Data are expressed as a percentage of the
maximum luminescence per live nematode (prior to freezing). Error
bars represent the S.E.M. of four replicate extracts.
Fig. 4. In vitro luminescence of extracts of nematodes exposed to
(A) copper and (B) 3,5-DCP. Data are expressed as a percentage of
the maximum luminescence per live nematode (prior to freezing).
Error bars represent the S.E.M. of three (copper) or four (3,5-DCP)
replicate extracts.
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crease in light. Reduction in light on exposure to lead was
caused mainly by an increase in mortality. However, exposure
to heat shock, copper and 3,5-DCP resulted in a decline in
luminescence due to a lower metabolic state of surviving nem-
atodes. Luciferase is degraded rapidly with a half-life of 3 h in
mammalian cells and 45 min in E. coli [14]. Di¡erential ex-
pression of luciferase and the enzyme’s instability could have
resulted in lower levels of active luciferase in animals exposed
to more adverse conditions. Levels of active luciferase were
assessed by in vitro assays and did not correlate with the in
vivo luminescence measurements, excluding the above hypoth-
esis. The decrease in luminescence in nematodes exposed to
elevated temperatures, copper and 3,5-DCP re£ected their
ATP levels and thus metabolic state. The strong causal link
between in vivo luminescence and cellular ATP levels has been
demonstrated previously [6]. The in vivo assay provides a
rapid measure of sublethal e¡ects of toxicity. In addition, as
illustrated by lead exposure, bioluminescence assays provide a
much faster measure of acute toxicity than conventional
methods.
Traditional toxicity assays rely mainly on assessment of
lethality and results are expressed as concentrations of toxi-
cant causing 50% lethality (LC50) after a certain exposure
time. Reported copper and lead 24 h LC50 values [3,15^20]
were respectively 2^13-fold higher and up to 4.5-fold higher
than those depressing luminescence by half in 2 h in the
present study (approximately 0.16 mM copper and 0.45 mM
lead). Thus, besides being faster and less labour intensive,
bioluminescence assays are a more sensitive method for as-
sessing toxicity than conventional lethality assays. Any envi-
ronmental condition that can impair metabolism, disrupt the
electron transport chain and activate protective mechanisms
that require energy expenditure will have some e¡ect on lumi-
nescence [21].
Transgenic C. elegans with the lacZ gene under control of
heat shock promoters have been developed and show promise
as biosensors [2,22^24]. However, when compared with lumi-
nescence, such assays are lengthy to perform and present some
technical di⁄culties as not all animals show induction of the
transgene. This makes spectrophotometric determination of L-
galactosidase less reliable than in situ histochemical staining,
which in turn is di⁄cult to quantify [22]. In addition, exposure
conditions for minimum staining (0.074 mM copper for 8 h or
0.030 mM lead for 16 h [24]) show that sensitivity is not
improved when compared to that of the bioluminescence as-
says developed here.
Bioluminescent biosensors have the advantage of being a
rapid, sensitive and easily quanti¢able method for assessing
toxicity. Luminescence provides integrated information on the
e¡ects of test conditions on the metabolism of the whole or-
ganism. The assays lend themselves well to rapid screening
and we are currently adapting them to a 96 well microplate
format.
C. elegans biosensors represent a more complex level of
biological organisation and a higher trophic level than the
bacterial and yeast luminescent biosensors already available
[1,7]. This is pertinent when predicting toxicity to humans or
implications for environmental health. This approach can be
used more generally to evaluate C. elegans metabolic status
and might be especially useful in ageing studies [25] and for
the development and screening of new nematocide drugs.
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